plasmacytoma
plasmacytoma
Explore linked clinical trials. Standard reference: MONDO:00056156 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Engineered Dendritic Cell Vaccines for Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, plasmacytoma, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 1 | 2026-08-27 | NCT06435910 | |
| Frontline Combination CAR-T Cell Therapy for Multiple Myeloma or Plasmacytoma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, plasmacytoma, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 1 / Phase 2 | 2026-08-27 | NCT06429150 | |
| FAPI PET Imaging - An Exploratory Study | Blood Protein Disorders, Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Genital Diseases, Head and Neck Neoplasms, Hemic and Lymphatic Diseases, Hypersensitivity, Delayed, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Pancreatic cancer, adult, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, adenoma, breast cancer, breast disorder, breast neoplasm, carcinoma, cardiovascular disorder, cirrhosis of liver, digestive system disorder, digestive system neoplasm, disease, endocrine system disorder, endometriosis, epithelial neoplasm, female reproductive system disorder, gastric neoplasm, hematologic disorder, hemorrhagic disease, hepatocellular carcinoma, immune system disorder, immunoproliferative disorder, interstitial lung disease, liver disorder, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, mesothelial neoplasm, mesothelioma, monoclonal gammopathy, neoplasm, plasma cell neoplasm, plasmacytoma, prostate cancer, prostate disorder, pulmonary fibrosis, respiratory system disorder, sarcoidosis, skin disorder, stomach disorder, thyroid gland disorder, thyroid tumor, transitional cell carcinoma, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 1 / Phase 2 | 2026-07-15 | NCT07705074 | |
| A Study of Lenalidomide and CC-486 With Radiation Therapy in Patients With Plasmacytoma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, plasmacytoma, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2025-12-02 | NCT04174196 | |
| The Indiana Myeloma Registry | Blood Protein Disorders, Hemic and Lymphatic Diseases, Hypergammaglobulinemia, Neoplasms by Histologic Type, Plasma Cell Dyscrasias, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, neoplasm, plasma cell neoplasm, plasmacytoma, precancerous condition, smoldering plasma cell myeloma, vascular disorder, vascular hemostatic disease | Recruiting | Not stated | 2025-11-10 | NCT03616483 | |
| Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma | Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, neoplasm, plasma cell neoplasm, plasmacytoma | Active, not recruiting | Phase 3 | 2022-12-23 | NCT02544308 |